| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |